Joel Kremer graduated from Temple University School of Medicine where he was elected to Alpha Omega Alpha, and trained in Internal Medicine and Rheumatology at Albany Medical Center Hospital, and Albany Medical College. He joined the faculty there in 1979, and became a full professor in 1990 when he assumed the title of Head of the Division of Rheumatology. In 2000, he became Director of Research at The Center for Rheumatology in Albany, NY and is the Pfaff Family Professor of Medicine at the Albany Medical College. He regularly teaches fellow and residents. His research interests have been in the area of therapeutics in patients with rheumatoid arthritis, as well as dietary intervention in this area. He has published extensively on methotrexate and more recently on biologic and small molecule therapeutic trials for RA and Comparative Effectiveness. He is the recipient of the Engalaticheff Award given by The Arthritis Foundation for “contributions which improve the quality of life of patients with arthritis” in 1997, and is a 2013 Master of the ACR. He is the author of over 230 peer-reviewed manuscript publications, 20 chapters and 6 texts. He is founder of Corrona, LLC and CMO of that organization. He is President of the CORRONA Research Foundation.